Scientists have pioneered a groundbreaking method to combat snake venom using newly designed proteins, offering hope for more effective, accessible, and affordable antivenom solutions.
By utilizing advanced computational techniques and deep learning, this innovative approach has already shown promising results in neutralizing deadly toxins, potentially transforming antivenom development, and offering new strategies for tackling other neglected diseases.
Breakthrough in Antivenom Research
Scientists have designed new proteins — unlike any found in nature — that can neutralize some of the most toxic components of snake venom. Using advanced deep learning and computational methods, researchers have developed these proteins with the potential to create safer, more affordable, and widely accessible treatments compared to existing antivenoms.
Each year, over 2 million people suffer from snakebites, with more than 100,000 deaths and 300,000 cases of severe complications, including limb deformities, amputations, and other long-term disabilities, according to the World Health Organization. The highest burden of snakebites is seen in regions such as Sub-Saharan Africa, South Asia, Papua New Guinea, and Latin America, where access to effective treatment is often limited.
Advancements in Computational Biology
This groundbreaking computational biology research, aimed at improving antivenom therapies, was led by scientists from the UW Medicine Institute for Protein Design and the Technical University of Denmark. Their findings were published in Nature on January 15.
The lead author of the paper is Susana Vazquez Torres of the Department of Biochemistry at the UW School of Medicine and the UW Graduate Program in Biological Physics. Her hometown is Querétaro, Mexico, which is located near viper and rattlesnake habitats. Her professional goal is to invent new drugs for neglected diseases and injuries, including snakebites.

The Challenge of Elapid Snakebites
Her research team, which also included international experts in snakebite research, drugs and diagnostics, and tropical medicine from the United Kingdom and Denmark, concentrated their attention on finding ways to neutralize venom gathered from certain elapids. Elapids are a large group of poisonous snakes, among them cobras and mambas, that live in the tropics and subtropics.
Most elapid species have two small fangs shaped like shallow needles. During a tenacious bite, the fangs can inject venom from glands at the back of the snake’s jaw. Among the venom’s components are potentially lethal three-finger toxins. These chemicals damage bodily tissues by killing cells. More seriously, by interrupting signals between nerves and muscles, three-finger toxins can cause paralysis and death.
Limitations of Current Treatments
At present, venomous snakebites from elapids are treated with antibodies taken from the plasma of animals that have been immunized against the snake toxin. Producing the antibodies is costly, and they have limited effectiveness against three-finger toxins. This treatment can also have serious side effects, including causing the patient to go into shock or respiratory distress.
“Efforts to try to develop new drugs have been slow and laborious,” noted Vazquez Torres.
Innovations in Protein Design
The researchers used deep learning computational methods to try to speed the discovery of better treatments. They created new proteins that interfered with the neurotoxic and cell-destroying properties of the three-finger toxin chemicals by binding with them.
Through experimental screening, the scientists obtained designs that generated proteins with thermal stability and high binding affinity. The actual synthesized proteins were almost a complete match at the atomic level with the deep-learning computer design.
In lab dishes, the designed proteins effectively neutralized all three of the subfamilies of three-finger toxins tested. When given to mice, the designed proteins protected the animals from what could have been a lethal neurotoxin exposure.
Promising Results and Future Directions
Designed proteins have key advantages. They could be manufactured with consistent quality through recombinant DNA technologies instead of by immunizing animals. (Recombinant DNA technologies in this case refer to the lab methods the scientists employed to take a computationally designed blueprint for a new protein and synthesize that protein.)
Also, the new proteins designed against snake toxins are small, compared to antibodies. Their smaller size might allow for greater penetration into tissues to quickly counteract the toxins and reduce damage.
Expanding the Potential of Computational Design
In addition to opening new avenues to develop antivenoms, the researchers think computational design methods could be used to develop other antidotes. Such methods also might be used to discover medications for undertreated illnesses that affect countries with significantly limited scientific research resources.
“Computational design methodology could substantially reduce the costs and resource requirements for development of therapies for neglected tropical diseases,” the researchers noted.
Explore Further: AI Triumphs Over Venom: Revolutionary Snakebite Antidotes Unveiled
Reference: “De novo designed proteins neutralize lethal snake venom toxins” by Susana Vázquez Torres, Melisa Benard Valle, Stephen P. Mackessy, Stefanie K. Menzies, Nicholas R. Casewell, Shirin Ahmadi, Nick J. Burlet, Edin Muratspahić, Isaac Sappington, Max D. Overath, Esperanza Rivera-de-Torre, Jann Ledergerber, Andreas H. Laustsen, Kim Boddum, Asim K. Bera, Alex Kang, Evans Brackenbrough, Iara A. Cardoso, Edouard P. Crittenden, Rebecca J. Edge, Justin Decarreau, Robert J. Ragotte, Arvind S. Pillai, Mohamad Abedi, Hannah L. Han, Stacey R. Gerben, Analisa Murray, Rebecca Skotheim, Lynda Stuart, Lance Stewart, Thomas J. A. Fryer, Timothy P. Jenkins and David Baker, 15 January 2025, Nature.
DOI: 10.1038/s41586-024-08393-x
The senior researchers on the project to design protein treatments for elapid snakebites were Timothy J. Perkins at the Technical University of Denmark and David Baker of the UW Medicine Institute for Protein Design and the Howard Hughes Medical Institute. Baker is a professor of biochemistry at the UW School of Medicine.
The University of Washington has submitted a provisional U.S. patent application for the design and composition of the proteins created in this study.

News
New Once-a-Week Shot Promises Life-Changing Relief for Parkinson’s Patients
A once-a-week shot from Australian scientists could spare people with Parkinson’s the grind of taking pills several times a day. The tiny, biodegradable gel sits under the skin and releases steady doses of two [...]
Weekly injectable drug offers hope for Parkinson’s patients
A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, potentially replacing the need for multiple daily tablets. Scientists from the University of South Australia [...]
Most Plastic in the Ocean Is Invisible—And Deadly
Nanoplastics—particles smaller than a human hair—can pass through cell walls and enter the food web. New research suggest 27 million metric tons of nanoplastics are spread across just the top layer of the North [...]
Repurposed drugs could calm the immune system’s response to nanomedicine
An international study led by researchers at the University of Colorado Anschutz Medical Campus has identified a promising strategy to enhance the safety of nanomedicines, advanced therapies often used in cancer and vaccine treatments, [...]
Nano-Enhanced Hydrogel Strategies for Cartilage Repair
A recent article in Engineering describes the development of a protein-based nanocomposite hydrogel designed to deliver two therapeutic agents—dexamethasone (Dex) and kartogenin (KGN)—to support cartilage repair. The hydrogel is engineered to modulate immune responses and promote [...]
New Cancer Drug Blocks Tumors Without Debilitating Side Effects
A new drug targets RAS-PI3Kα pathways without harmful side effects. It was developed using high-performance computing and AI. A new cancer drug candidate, developed through a collaboration between Lawrence Livermore National Laboratory (LLNL), BridgeBio Oncology [...]
Scientists Are Pretty Close to Replicating the First Thing That Ever Lived
For 400 million years, a leading hypothesis claims, Earth was an “RNA World,” meaning that life must’ve first replicated from RNA before the arrival of proteins and DNA. Unfortunately, scientists have failed to find [...]
Why ‘Peniaphobia’ Is Exploding Among Young People (And Why We Should Be Concerned)
An insidious illness is taking hold among a growing proportion of young people. Little known to the general public, peniaphobia—the fear of becoming poor—is gaining ground among teens and young adults. Discover the causes [...]
Team finds flawed data in recent study relevant to coronavirus antiviral development
The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid this effort, researchers quickly homed in on part of SARS-CoV-2's molecular structure known as the NiRAN domain—an [...]
Drug-Coated Neural Implants Reduce Immune Rejection
Summary: A new study shows that coating neural prosthetic implants with the anti-inflammatory drug dexamethasone helps reduce the body’s immune response and scar tissue formation. This strategy enhances the long-term performance and stability of electrodes [...]
Scientists discover cancer-fighting bacteria that ‘soak up’ forever chemicals in the body
A family of healthy bacteria may help 'soak up' toxic forever chemicals in the body, warding off their cancerous effects. Forever chemicals, also known as PFAS (per- and polyfluoroalkyl substances), are toxic chemicals that [...]
Johns Hopkins Researchers Uncover a New Way To Kill Cancer Cells
A new study reveals that blocking ribosomal RNA production rewires cancer cell behavior and could help treat genetically unstable tumors. Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Radiation Oncology and Molecular [...]
AI matches doctors in mapping lung tumors for radiation therapy
In radiation therapy, precision can save lives. Oncologists must carefully map the size and location of a tumor before delivering high-dose radiation to destroy cancer cells while sparing healthy tissue. But this process, called [...]
Scientists Finally “See” Key Protein That Controls Inflammation
Researchers used advanced microscopy to uncover important protein structures. For the first time, two important protein structures in the human body are being visualized, thanks in part to cutting-edge technology at the University of [...]
AI tool detects 9 types of dementia from a single brain scan
Mayo Clinic researchers have developed a new artificial intelligence (AI) tool that helps clinicians identify brain activity patterns linked to nine types of dementia, including Alzheimer's disease, using a single, widely available scan—a transformative [...]
Is plastic packaging putting more than just food on your plate?
New research reveals that common food packaging and utensils can shed microscopic plastics into our food, prompting urgent calls for stricter testing and updated regulations to protect public health. Beyond microplastics: The analysis intentionally [...]